2BKT

crystal structure of renin-pf00257567 complex


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.291 (Depositor) 
  • R-Value Work: 
    0.244 (Depositor), 0.248 (DCC) 
  • R-Value Observed: 
    0.244 (Depositor) 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 

Created with Raphaël 2.3.0Worse 01 BetterLigand structure goodness of fit to experimental dataBest fitted RPFClick on this verticalbar to view details

This is version 1.3 of the entry. See complete history


Literature

Equipotent Activity in Both Enantiomers of a Series of Ketopiperazine-Based Renin Inhibitors

Powell, N.A.Clay, E.H.Holsworth, D.D.Bryant, J.W.Ryan, J.M.Jalaie, M.Zhang, E.Edmunds, J.J.

(2005) Bioorg Med Chem Lett 15: 2371

  • DOI: https://doi.org/10.1016/j.bmcl.2005.02.085
  • Primary Citation of Related Structures:  
    2BKS, 2BKT

  • PubMed Abstract: 

    We have found that both enantiomeric configurations of the 6-alkoxymethyl-1-aryl-2-piperazinone scaffold display equipotent renin inhibition activity and similar SAR patterns. This enantiomeric flexibility is in contrast to a previously reported 3-alkoxymethyl-4-arylpiperidine scaffold.


  • Organizational Affiliation

    Pfizer Global Research and Development, Michigan Laboratories, Ann Arbor, MI 48105, USA. noel.powell@pfizer.com


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
RENIN
A, B
340Homo sapiensMutation(s): 0 
EC: 3.4.23.15
UniProt & NIH Common Fund Data Resources
Find proteins for P00797 (Homo sapiens)
Explore P00797 
Go to UniProtKB:  P00797
PHAROS:  P00797
GTEx:  ENSG00000143839 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00797
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
RPF
Query on RPF

Download Ideal Coordinates CCD File 
C [auth A],
D [auth B]
1-{4-[3-(2-METHOXY-BENZYLOXY)-PROPOXY]-PHENYL}-6-(1,2,,3,4-TETRAHYDRO-QUINOLIN-7-YLOXYMETHYL)-PIPERAZIN-2-ONE
C31 H37 N3 O5
JXFXZCANEQOOHW-SANMLTNESA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
RPF BindingDB:  2BKT IC50: 23 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.291 (Depositor) 
  • R-Value Work:  0.244 (Depositor), 0.248 (DCC) 
  • R-Value Observed: 0.244 (Depositor) 
Space Group: P 21 3
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 138.895α = 90
b = 138.895β = 90
c = 138.895γ = 90
Software Package:
Software NamePurpose
CNSrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 

Created with Raphaël 2.3.0Worse 01 BetterLigand structure goodness of fit to experimental dataBest fitted RPFClick on this verticalbar to view details

Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2006-04-05
    Type: Initial release
  • Version 1.1: 2011-05-08
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2024-11-13
    Changes: Data collection, Database references, Derived calculations, Other, Structure summary